Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Using skin stem cells and certain molecules might lead to scar-free skin healing.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

The document is a detailed medical reference on skin and genetic disorders.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Dupilumab for skin problems might reactivate hair loss in some patients.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

A woman developed a rare scalp condition after starting minoxidil, which was resolved with specific shampoo and solution.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Denosumab treatment for osteoporosis can cause hair loss.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

New genetic discoveries may lead to better treatments for alopecia areata.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Autoimmune and metabolic issues are linked, and treating one may worsen another.